These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling. Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621 [TBL] [Abstract][Full Text] [Related]
9. p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. Carta L; Smaldone S; Zilberberg L; Loch D; Dietz HC; Rifkin DB; Ramirez F J Biol Chem; 2009 Feb; 284(9):5630-6. PubMed ID: 19109253 [TBL] [Abstract][Full Text] [Related]
10. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response. Tu AW; Luo K J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422 [TBL] [Abstract][Full Text] [Related]
11. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696 [TBL] [Abstract][Full Text] [Related]
12. Oxidative stress is responsible for maternal diabetes-impaired transforming growth factor beta signaling in the developing mouse heart. Wang F; Reece EA; Yang P Am J Obstet Gynecol; 2015 May; 212(5):650.e1-11. PubMed ID: 25595579 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts. Li T; Zhao J Mol Med Rep; 2018 Mar; 17(3):4057-4061. PubMed ID: 29286129 [TBL] [Abstract][Full Text] [Related]
14. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis. Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897 [TBL] [Abstract][Full Text] [Related]
15. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487 [TBL] [Abstract][Full Text] [Related]
16. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability. Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II. Wicks SJ; Lui S; Abdel-Wahab N; Mason RM; Chantry A Mol Cell Biol; 2000 Nov; 20(21):8103-11. PubMed ID: 11027280 [TBL] [Abstract][Full Text] [Related]
18. Kaurenoic acid activates TGF-β signaling. Kim KH; Han JW; Jung SK; Park BJ; Han CW; Joo M Phytomedicine; 2017 Aug; 32():8-14. PubMed ID: 28732811 [TBL] [Abstract][Full Text] [Related]